Fanny Collado

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search

Fanny Collado is Research Nurse Coordinator and Health Science Specialist at the Institute for Neuro-Immune Medicine at Nova Southeastern University (NSU) in Florida.[1]

Early life and education[edit | edit source]

Collado was born and raised in New York City and moved to Miami in 1994.[1] She attended Barry University, ultimately graduating with a degree in nursing.[1]

Career[edit | edit source]

Collado serves as Research Nurse Coordinator and Health Science Specialist at the Institute for Neuro-Immune Medicine at Nova Southeastern University (NSU).[1] She has also served as Research Nurse Coordinator at the Miami VA Hospital.[1]

Notable studies[edit | edit source]

  • 2016, Illness progression in chronic fatigue syndrome: A shifting immune baseline[2]
  • 2020, Unravelling myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Gender‐specific changes in the microRNA expression profiling in ME/CFS[3] - (Full text)

Personal life[edit | edit source]

Collado has three children.[1]

References[edit | edit source]

  1. 1.01.11.21.31.41.5 NSU. "Our Team | Clinical Research | NSU Institute for Neuro Immune Medicine". NSU. Nova Southeastern University. Retrieved Jan 11, 2019. 
  2. Russell, Lindsey; Broderick, Gordon; Taylor, Renee; Fernandes, Henrique; Harvey, Jeanna; Barnes, Zachary; Smylie, AnneLiese; Collado, Fanny; Balbin, Elizabeth G. (Mar 10, 2016). "Illness progression in chronic fatigue syndrome: a shifting immune baseline". BMC Immunology. 17 (1): 3. doi:10.1186/s12865-016-0142-3. ISSN 1471-2172. PMC 4785654Freely accessible. PMID 26965484. 
  3. Cheema, Amanpreet K.; Sarria, Leonor; Bekheit, Mina; Collado, Fanny; Almenar‐Pérez, Eloy; Martín‐Martínez, Eva; Alegre, Jose; Castro‐Marrero, Jesus; Fletcher, Mary A.; Klimas, Nancy; Oltra, Elisa; Nathanson, Lubov (Apr 14, 2020). "Unravelling myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Gender-specific changes in the microRNA expression profiling in ME/CFS". Journal of Cellular and Molecular Medicine. 00: 1–13. doi:10.1111/jcmm.15260. ISSN 1582-4934. PMID 32291908. 

chronic fatigue syndrome (CFS) - A fatigue-based illness. The term CFS was invented invented by the U.S. Centers for Disease Control as an replacement for myalgic encephalomyelitis (ME). Some view CFS as a neurological disease, others use the term for any unexplained long-term fatigue. Sometimes used as a the term as a synonym of myalgic encephalomyelitis, despite the different diagnostic criteria.

myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

ME/CFS - An acronym that combines myalgic encephalomyelitis with chronic fatigue syndrome. Sometimes they are combined because people have trouble distinguishing one from the other. Sometimes they are combined because people see them as synonyms of each other.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.